Stay updated on FT538 with Daratumumab in AML Clinical Trial
Sign up to get notified when there's something new on the FT538 with Daratumumab in AML Clinical Trial page.

Latest updates to the FT538 with Daratumumab in AML Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the record history.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedThe revision history shows a new revision label (v3.4.2) replacing the previous v3.4.1; this is a cosmetic update with no substantive content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision tag 'Revision: v3.4.1' appears, replacing the previous 'Revision: v3.4.0' in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedUI updates on the record history page add a glossary toggle, emphasize changes with green/red highlights, and show revision/version information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check67 days agoChange DetectedA new page revision was added to the history: v3.3.4, replacing the prior revision v3.3.3. To avoid alerts for small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to FT538 with Daratumumab in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT538 with Daratumumab in AML Clinical Trial page.